Open Access Open Access  Restricted Access Subscription Access
Cover Image

Altered profile of circulating myokines as a predictor of poor prognosis in heart failure

Alexander E. Berezin, Alexander A. Berezin, Sergii Myrnyi

Abstract


Background: The myokines are produced predominantly by skeletal muscle cells in response to physical activity and regulate metabolic homeostasis, proliferation, angiogenesis, neovascularization, reparation and neurogenesis in skeletal muscle tissue. HF is strongly associated with decrease in physical endurance and led to myopathy having established negative impact on the clinical outcomes and quality of life.

The aim of the narrative mini review is depicted the role of the myokines in patients with heart failure (HF).

Methods: Search in the data bases including SCOPUS, Web of Science, PubMed, Copernicus.

Result: Impaired myokine (irisin, myostatin, myonectin, brain-derived neurotrophic factor, interleukins [IL]-6, IL-8, IL-15, tumor necrosis factor-alpha, fibroblast growth factor 21, growth differential factor-11) profile has been found in patients with HF regardless of phenotypes of cardiac dysfunction and, so important, prior to sarcopenia. It has been postulated that altered profile of the myokines can improve a stratification of HF patients at higher risk of poor clinical outcomes independently left ventricular ejection fraction and metabolic disease presentation. 

Conclusion: Myokines are involved in skeletal muscle myopathy and the evaluation of their circulating levels could provide new insights to the course of HF and stratify patients at higher risk of poor outcomes prior to sarcopenic stage. The large clinical trials are needed whether myokines are predictive biomarkers that are independently associated with an increased risk of HF-related mortality and clinical outcomes.

Keywords


heart failure; myokines; outcomes; sarcopenia; risk stratification; prognosis.

Full Text:

PDF

References


Li F, Li Y, Duan Y, Hu CA, Tang Y, Yin Y. Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 2017; 33:73-82. doi: 10.1016/j.cytogfr.2016.10.003.

Chung HS, Choi KM. Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders. Curr Med Chem. 2018; 25(20):2401-2415. doi:10.2174/0929867325666171205144627

Nakano I, Kinugawa S, Hori H, Fukushima A, Yokota T, Takada S, et al. Serum Brain-Derived Neurotrophic Factor Levels Are Associated with Skeletal Muscle Function but Not with Muscle Mass in Patients with Heart Failure. Int Heart J. 2020; 61(1):96-102. doi: 10.1536/ihj.19-400.

Di Raimondo D, Tuttolomondo A, Musiari G, Schimmenti C, D'Angelo A, Pinto A. Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?. Curr Pharm Des. 2016; 22(24):3622-3647. doi:10.2174/1381612822666160429121934

Berezin AE, Berezin AA. Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk. Diabetes Metab Syndr. 2019; 13(4):2549-2556. doi:10.1016/j.dsx.2019.07.018

Silva AP, Mendes F, Carias E, Gonçalves RB, Fragoso A, Dias C, et al. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients. Int J Mol Sci. 2019; 20(7):1536. doi: 10.3390/ijms20071536.

Berezin AE. Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?. Diabetes Metab Syndr. 2017; 11 Suppl 1:S201-S208. doi:10.1016/j.dsx.2016.12.032

Paneroni M, Pasini E, Comini L, Vitacca M, Schena F, Scalvini S, Venturelli M. Skeletal Muscle Myopathy in Heart Failure: the Role of Ejection Fraction. Curr Cardiol Rep. 2018; 20(11):116. doi: 10.1007/s11886-018-1056-x. PMID: 30259199.

Tzanis G, Philippou A, Karatzanos E, Dimopoulos S, Kaldara E, Nana E, et al. Effects of High-Intensity Interval Exercise Training on Skeletal Myopathy of Chronic Heart Failure. J Card Fail. 2017; 23(1):36-46. doi: 10.1016/j.cardfail.2016.06.007..

Poole DC, Hirai DM, Copp SW, Musch TI. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol. 2012; 302(5):H1050-H1063. doi:10.1152/ajpheart.00943.2011.

Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, Cleland JG, Colucci WS, Butler J, Voors AA, Anker SD, Pitt B, Pieske B, Filippatos G, Greene SJ, Gheorghiade M. Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14(4):238-250. doi: 10.1038/nrcardio.2016.203.

Brum PC, Bacurau AV, Cunha TF, Bechara LR, Moreira JB. Skeletal myopathy in heart failure: effects of aerobic exercise training. Exp Physiol. 2014; 99(4):616-620. doi:10.1113/expphysiol.2013.076844

Lavine KJ, Sierra OL. Skeletal muscle inflammation and atrophy in heart failure. Heart Fail Rev. 2017; 22(2):179-189. doi:10.1007/s10741-016-9593-0

Abd El-Mottaleb NA, Galal HM, El Maghraby KM, Gadallah AI. Serum irisin level in myocardial infarction patients with or without heart failure. Can J Physiol Pharmacol. 2019; 97(10):932-938. doi:10.1139/cjpp-2018-0736

Otaka N, Shibata R, Ohashi K, Uemura Y, Kambara T, Enomoto T, et al. Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury. Circ Res. 2018;123(12):1326-1338. doi: 10.1161/CIRCRESAHA.118.313777.

Olsen T, Øvrebø B, Haj-Yasein N, Lee S, Svendsen K, Hjorth M, et al. Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study. J Transl Med. 2020; 18(1):122. doi: 10.1186/s12967-020-02288-x.

Ishida J, Konishi M, Saitoh M, Anker M, Anker SD, Springer J. Myostatin signaling is up-regulated in female patients with advanced heart failure. Int J Cardiol. 2017; 238:37-42. doi:10.1016/j.ijcard.2017.03.153

Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004; 22(3):123-131. doi:10.1080/08977190410001723308

Segiet OA, Piecuch A, Mielanczyk L, Michalski M, Nowalany-Kozielska E. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 2019; 22(6):287-299. doi:10.14744/AnatolJCardiol.2019.32748

Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006; 17(4):259-280. doi:10.1016/j.cytogfr.2006.05.001

Sente T, Van Berendoncks AM, Jonckheere AI, Rodenburg RJ, Lauwers P, Van Hoof V, et al. Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity. BMC Cardiovasc Disord. 2016;16:107. doi: 10.1186/s12872-016-0278-3.

Batista ML Jr, Rosa JC, Lopes RD, Lira FS, Martins E Jr, Yamashita AS, et al. Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine. 2010; 49(1):102-8. doi: 10.1016/j.cyto.2009.10.007.

Goletti S, Gruson D. Personalized risk assessment of heart failure patients: more perspectives from transforming growth factor super-family members. Clin Chim Acta. 2015; 443:94-99. doi:10.1016/j.cca.2014.09.014

Silvestrini A, Bruno C, Vergani E, Venuti A, Favuzzi AMR, Guidi F, et al. Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study. PLoS One. 2019; 14(1):e0210320. doi: 10.1371/journal.pone.0210320.

Fukushima A, Kinugawa S, Homma T, Masaki Y, Furihata T, Yokota T, et al. Serum brain-derived neurotropic factor level predicts adverse clinical outcomes in patients with heart failure. J Card Fail. 2015; 21(4):300-6. doi: 10.1016/j.cardfail.2015.01.003.

Lopez PD, Nepal P, Akinlonu A, Nekkalapudi D, Kim K, Cativo EH, et al. Low Skeletal Muscle Mass Independently Predicts Mortality in Patients with Chronic Heart Failure after an Acute Hospitalization. Cardiology. 2019; 142(1):28-36. doi: 10.1159/000496460.

Matsuo Y, Gleitsmann K, Mangner N, Werner S, Fischer T, Bowen TS, et al. Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines. J Cachexia Sarcopenia Muscle. 2015;6(1):62-72. doi: 10.1002/jcsm.12006

Duan J, Zhu B, Wu Y, Chen Z, Yang L. Myokines: An Available Biomarker to Evaluate Cardiac Functions?. Cardiology. 2019; 142(4):211-212. doi:10.1159/000500320

Hsieh IC, Ho MY, Wen MS, Chen CC, Hsieh MJ, Lin CP, et al. Serum irisin levels are associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Int J Cardiol. 2018; 261:12-17. doi: 10.1016/j.ijcard.2017.11.072.

Takada S, Sabe H, Kinugawa S. Abnormalities of Skeletal Muscle, Adipocyte Tissue, and Lipid Metabolism in Heart Failure: Practical Therapeutic Targets. Front Cardiovasc Med. 2020; 7:79. doi:10.3389/fcvm.2020.00079


Refbacks

  • There are currently no refbacks.